← All tickers

Is FATE Worth Buying in 2026?

Fate Therapeutics, Inc.

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-05-24

Here’s whether Fate Therapeutics, Inc. (FATE) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+9.52% over 10 days); RSI 60 — healthy momentum range; strong 1-year return of +87.5%; 3-month momentum positive (+38.9%); rising volume confirms the move (1.24x 30d avg). Currently 8.7% off its 52-week high. Score: +8/7.

Ready to act on this? 📈 Trade on Webull

FATE is in a confirmed uptrend, trading above both its 50-day ($1.50) and 200-day ($1.25) moving averages. An RSI of 60.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +87.5% compares to +27.9% for SPY (beat the market by 59.6%).

$10,000 invested 1 year ago → $18,750 today
vs. S&P 500 (SPY) — same period beat market by 59.6%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($1.25)
✓Above 50-day MA ($1.50)
✓RSI(14) neutral zone (30–70) — currently 60.1
✓Positive return (+87.5%)
✓Within 10% of period high (−8.7%)
Period Range $2.25
$0.91 $2.47
RSI (14) 60.1
0 · OversoldOverbought · 100

Key Metrics

Price$2.25
Period Return+87.5%
Period High$2.47
Period Low$0.91
Drawdown−8.7%
MA-50$1.50
MA-200$1.25
RSI (14)60.1
Avg Volume (30d)3.1M
vs. SPYbeat by 59.6%
Return Rank#261 of 1236

Trade FATE

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers